| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |